Aberrant Gut Microbiome Contributes to Barrier Dysfunction, Inflammation, and Local Immune Responses in IgA Nephropathy
Introduction: Numerous research works have shown that serum Gal-deficient (Gd) IgA1 levels are increased in IgA nephropathy (IgAN) patients and these levels are a dangerous risk factor for IgAN. A relationship between the gut microbiota and IgAN has been reported. Whether the gut microbiota particip...
Main Authors: | Yuyan Tang, Yong Xiao, Haidong He, Yifan Zhu, Weiqian Sun, Ping Hu, Xudong Xu, Zhen Liu, Zhaowei Yan, Minggang Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2023-03-01
|
Series: | Kidney & Blood Pressure Research |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/528973 |
Similar Items
-
Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
by: Yoshihito Nihei, et al.
Published: (2023-04-01) -
Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know
by: Yukako Ohyama, et al.
Published: (2021-08-01) -
Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
by: Jin Sug Kim, et al.
Published: (2020-11-01) -
Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?
by: Renato C. Monteiro, et al.
Published: (2022-03-01) -
Systematic Microbiome Dysbiosis Is Associated with IgA Nephropathy
by: Fengtao Cai, et al.
Published: (2023-06-01)